Global Precision Cancer Diagnostic Tests Market Growth Forecast Report 2025-2031

Global Info Research released “Global Precision Cancer Diagnostic Tests Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031”. This report includes an overview of the development of the Precision Cancer Diagnostic Tests industry chain, the market status of Precision Cancer Diagnostic Tests Market, and key Players in developed and Precision Cancer Diagnostic Tests market, and analyze the cutting-edge technology, patent, hot applications and market trends of Precision Cancer Diagnostic Tests industry.

According to our latest research, the global Precision Cancer Diagnostic Tests market size will reach USD 12250 million in 2031, growing at a CAGR of 12.2% over the analysis period.

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Precision Cancer Diagnostic Tests product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Precision Cancer Diagnostic Tests, with revenue, gross margin and global market share of Precision Cancer Diagnostic Tests from 2020 to 2025.
Chapter 3, the Precision Cancer Diagnostic Tests competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the Precision Cancer Diagnostic Tests market size by Type and application, with consumption value and growth rate by Type, application, from 2020 to 2031.
Chapter 6, 7, 8, 9, and 10, to break the Precision Cancer Diagnostic Tests market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Precision Cancer Diagnostic Tests market forecast, by regions, type and sales channel, with consumption value, from 2026 to 2031.
Chapter 11, Precision Cancer Diagnostic Tests market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Precision Cancer Diagnostic Tests.
Chapter 13, to describe Precision Cancer Diagnostic Tests research findings and conclusion.

Sample Report Request Precision Cancer Diagnostic Tests @:
https://www.globalinforesearch.com/reports/2793515/precision-cancer-diagnostic-tests

Table of Contents
 1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Precision Cancer Diagnostic Tests by Type
1.3.1 Overview: Global Precision Cancer Diagnostic Tests Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Precision Cancer Diagnostic Tests Consumption Value Market Share by Type in 2024
1.3.3 Imaging
1.3.4 Molecular
1.3.5 Histology/Cytology
1.3.6 Tumor Marker Immunoassays
1.3.7 POC Colon Cancer Tests
1.4 Global Precision Cancer Diagnostic Tests Market by Application
1.4.1 Overview: Global Precision Cancer Diagnostic Tests Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Precision Cancer Diagnostic Tests Market Size & Forecast
1.6 Global Precision Cancer Diagnostic Tests Market Size and Forecast by Region
1.6.1 Global Precision Cancer Diagnostic Tests Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Precision Cancer Diagnostic Tests Market Size by Region, (2020-2031)
1.6.3 North America Precision Cancer Diagnostic Tests Market Size and Prospect (2020-2031)
1.6.4 Europe Precision Cancer Diagnostic Tests Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Precision Cancer Diagnostic Tests Market Size and Prospect (2020-2031)
1.6.6 South America Precision Cancer Diagnostic Tests Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Precision Cancer Diagnostic Tests Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Product and Solutions
2.1.4 Abbott Laboratories Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Product and Solutions
2.2.4 Agilent Technologies Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Becton Dickinson and Company
2.3.1 Becton Dickinson and Company Details
2.3.2 Becton Dickinson and Company Major Business
2.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product and Solutions
2.3.4 Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Becton Dickinson and Company Recent Developments and Future Plans
2.4 Bio-Rad Laboratories
2.4.1 Bio-Rad Laboratories Details
2.4.2 Bio-Rad Laboratories Major Business
2.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product and Solutions
2.4.4 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.5 Biocartis N.V.
2.5.1 Biocartis N.V. Details
2.5.2 Biocartis N.V. Major Business
2.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Product and Solutions
2.5.4 Biocartis N.V. Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Biocartis N.V. Recent Developments and Future Plans
2.6 Biocept
2.6.1 Biocept Details
2.6.2 Biocept Major Business
2.6.3 Biocept Precision Cancer Diagnostic Tests Product and Solutions
2.6.4 Biocept Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Biocept Recent Developments and Future Plans
2.7 bioMerieux SA
2.7.1 bioMerieux SA Details
2.7.2 bioMerieux SA Major Business
2.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Product and Solutions
2.7.4 bioMerieux SA Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 bioMerieux SA Recent Developments and Future Plans
2.8 Canon Medical Systems Corporation
2.8.1 Canon Medical Systems Corporation Details
2.8.2 Canon Medical Systems Corporation Major Business
2.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product and Solutions
2.8.4 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Canon Medical Systems Corporation Recent Developments and Future Plans
2.9 Cynvenio Biosystems
2.9.1 Cynvenio Biosystems Details
2.9.2 Cynvenio Biosystems Major Business
2.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product and Solutions
2.9.4 Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Cynvenio Biosystems Recent Developments and Future Plans
2.10 Danaher Corporation
2.10.1 Danaher Corporation Details
2.10.2 Danaher Corporation Major Business
2.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Product and Solutions
2.10.4 Danaher Corporation Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Danaher Corporation Recent Developments and Future Plans
2.11 Epigenomics AG
2.11.1 Epigenomics AG Details
2.11.2 Epigenomics AG Major Business
2.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Product and Solutions
2.11.4 Epigenomics AG Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Epigenomics AG Recent Developments and Future Plans
2.12 Exosome Diagnostics
2.12.1 Exosome Diagnostics Details
2.12.2 Exosome Diagnostics Major Business
2.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Product and Solutions
2.12.4 Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Exosome Diagnostics Recent Developments and Future Plans
2.13 Foundation Medicine
2.13.1 Foundation Medicine Details
2.13.2 Foundation Medicine Major Business
2.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Product and Solutions
2.13.4 Foundation Medicine Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Foundation Medicine Recent Developments and Future Plans
2.14 General Electric Company
2.14.1 General Electric Company Details
2.14.2 General Electric Company Major Business
2.14.3 General Electric Company Precision Cancer Diagnostic Tests Product and Solutions
2.14.4 General Electric Company Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 General Electric Company Recent Developments and Future Plans
2.15 Genomic Health
2.15.1 Genomic Health Details
2.15.2 Genomic Health Major Business
2.15.3 Genomic Health Precision Cancer Diagnostic Tests Product and Solutions
2.15.4 Genomic Health Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Genomic Health Recent Developments and Future Plans
2.16 Hologic
2.16.1 Hologic Details
2.16.2 Hologic Major Business
2.16.3 Hologic Precision Cancer Diagnostic Tests Product and Solutions
2.16.4 Hologic Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Hologic Recent Developments and Future Plans
2.17 Illumina
2.17.1 Illumina Details
2.17.2 Illumina Major Business
2.17.3 Illumina Precision Cancer Diagnostic Tests Product and Solutions
2.17.4 Illumina Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Illumina Recent Developments and Future Plans
2.18 Menarini Silicon Biosystems SpA
2.18.1 Menarini Silicon Biosystems SpA Details
2.18.2 Menarini Silicon Biosystems SpA Major Business
2.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product and Solutions
2.18.4 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Menarini Silicon Biosystems SpA Recent Developments and Future Plans
2.19 Myriad Genetics
2.19.1 Myriad Genetics Details
2.19.2 Myriad Genetics Major Business
2.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Product and Solutions
2.19.4 Myriad Genetics Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Myriad Genetics Recent Developments and Future Plans
2.20 NanoString Technologies
2.20.1 NanoString Technologies Details
2.20.2 NanoString Technologies Major Business
2.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Product and Solutions
2.20.4 NanoString Technologies Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 NanoString Technologies Recent Developments and Future Plans
2.21 Ortho Clinical Diagnostics
2.21.1 Ortho Clinical Diagnostics Details
2.21.2 Ortho Clinical Diagnostics Major Business
2.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product and Solutions
2.21.4 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.22 QIAGEN N.V.
2.22.1 QIAGEN N.V. Details
2.22.2 QIAGEN N.V. Major Business
2.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Product and Solutions
2.22.4 QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 QIAGEN N.V. Recent Developments and Future Plans
2.23 Randox Laboratories Ltd.
2.23.1 Randox Laboratories Ltd. Details
2.23.2 Randox Laboratories Ltd. Major Business
2.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product and Solutions
2.23.4 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Randox Laboratories Ltd. Recent Developments and Future Plans
2.24 Roche Holding AG
2.24.1 Roche Holding AG Details
2.24.2 Roche Holding AG Major Business
2.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Product and Solutions
2.24.4 Roche Holding AG Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Roche Holding AG Recent Developments and Future Plans
2.25 Royal Philips N.V.
2.25.1 Royal Philips N.V. Details
2.25.2 Royal Philips N.V. Major Business
2.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Product and Solutions
2.25.4 Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Royal Philips N.V. Recent Developments and Future Plans
2.26 Siemens AG
2.26.1 Siemens AG Details
2.26.2 Siemens AG Major Business
2.26.3 Siemens AG Precision Cancer Diagnostic Tests Product and Solutions
2.26.4 Siemens AG Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Siemens AG Recent Developments and Future Plans
2.27 Thermo Fisher Scientific
2.27.1 Thermo Fisher Scientific Details
2.27.2 Thermo Fisher Scientific Major Business
2.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product and Solutions
2.27.4 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.27.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.28 Vela Diagnostics
2.28.1 Vela Diagnostics Details
2.28.2 Vela Diagnostics Major Business
2.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Product and Solutions
2.28.4 Vela Diagnostics Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2025)
2.28.5 Vela Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Precision Cancer Diagnostic Tests Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Precision Cancer Diagnostic Tests by Company Revenue
3.2.2 Top 3 Precision Cancer Diagnostic Tests Players Market Share in 2024
3.2.3 Top 6 Precision Cancer Diagnostic Tests Players Market Share in 2024
3.3 Precision Cancer Diagnostic Tests Market: Overall Company Footprint Analysis
3.3.1 Precision Cancer Diagnostic Tests Market: Region Footprint
3.3.2 Precision Cancer Diagnostic Tests Market: Company Product Type Footprint
3.3.3 Precision Cancer Diagnostic Tests Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Precision Cancer Diagnostic Tests Consumption Value and Market Share by Type (2020-2025)
4.2 Global Precision Cancer Diagnostic Tests Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Precision Cancer Diagnostic Tests Consumption Value Market Share by Application (2020-2025)
5.2 Global Precision Cancer Diagnostic Tests Market Forecast by Application (2026-2031)
6 North America
6.1 North America Precision Cancer Diagnostic Tests Consumption Value by Type (2020-2031)
6.2 North America Precision Cancer Diagnostic Tests Market Size by Application (2020-2031)
6.3 North America Precision Cancer Diagnostic Tests Market Size by Country
6.3.1 North America Precision Cancer Diagnostic Tests Consumption Value by Country (2020-2031)
6.3.2 United States Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
6.3.3 Canada Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
6.3.4 Mexico Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Precision Cancer Diagnostic Tests Consumption Value by Type (2020-2031)
7.2 Europe Precision Cancer Diagnostic Tests Consumption Value by Application (2020-2031)
7.3 Europe Precision Cancer Diagnostic Tests Market Size by Country
7.3.1 Europe Precision Cancer Diagnostic Tests Consumption Value by Country (2020-2031)
7.3.2 Germany Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
7.3.3 France Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
7.3.5 Russia Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
7.3.6 Italy Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Diagnostic Tests Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Precision Cancer Diagnostic Tests Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region
8.3.1 Asia-Pacific Precision Cancer Diagnostic Tests Consumption Value by Region (2020-2031)
8.3.2 China Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
8.3.3 Japan Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
8.3.4 South Korea Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
8.3.5 India Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
8.3.7 Australia Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
9 South America
9.1 South America Precision Cancer Diagnostic Tests Consumption Value by Type (2020-2031)
9.2 South America Precision Cancer Diagnostic Tests Consumption Value by Application (2020-2031)
9.3 South America Precision Cancer Diagnostic Tests Market Size by Country
9.3.1 South America Precision Cancer Diagnostic Tests Consumption Value by Country (2020-2031)
9.3.2 Brazil Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
9.3.3 Argentina Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Diagnostic Tests Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Precision Cancer Diagnostic Tests Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country
10.3.1 Middle East & Africa Precision Cancer Diagnostic Tests Consumption Value by Country (2020-2031)
10.3.2 Turkey Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
10.3.4 UAE Precision Cancer Diagnostic Tests Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Precision Cancer Diagnostic Tests Market Drivers
11.2 Precision Cancer Diagnostic Tests Market Restraints
11.3 Precision Cancer Diagnostic Tests Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Precision Cancer Diagnostic Tests Industry Chain
12.2 Precision Cancer Diagnostic Tests Upstream Analysis
12.3 Precision Cancer Diagnostic Tests Midstream Analysis
12.4 Precision Cancer Diagnostic Tests Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer


Contact Us
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888

Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.